Correlation Between DXC Technology and PDS Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DXC Technology and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DXC Technology and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DXC Technology Co and PDS Biotechnology Corp, you can compare the effects of market volatilities on DXC Technology and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DXC Technology with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of DXC Technology and PDS Biotechnology.

Diversification Opportunities for DXC Technology and PDS Biotechnology

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between DXC and PDS is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding DXC Technology Co and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and DXC Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DXC Technology Co are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of DXC Technology i.e., DXC Technology and PDS Biotechnology go up and down completely randomly.

Pair Corralation between DXC Technology and PDS Biotechnology

Assuming the 90 days trading horizon DXC Technology Co is expected to generate 0.29 times more return on investment than PDS Biotechnology. However, DXC Technology Co is 3.49 times less risky than PDS Biotechnology. It trades about 0.15 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.09 per unit of risk. If you would invest  1,920  in DXC Technology Co on October 29, 2024 and sell it today you would earn a total of  84.00  from holding DXC Technology Co or generate 4.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

DXC Technology Co  vs.  PDS Biotechnology Corp

 Performance 
       Timeline  
DXC Technology 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in DXC Technology Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, DXC Technology may actually be approaching a critical reversion point that can send shares even higher in February 2025.
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

DXC Technology and PDS Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DXC Technology and PDS Biotechnology

The main advantage of trading using opposite DXC Technology and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DXC Technology position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.
The idea behind DXC Technology Co and PDS Biotechnology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges